Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)

AstraZeneca

Status: Completed

Conditions: Hyperkalemia Elevated Plasma K+ Cardiovascular Disease (CVD)

Study type: Observational

Funder types: Industry

Identifiers

NCT03657875

D1843R00280

Details and patient eligibility

About

This is a cross-sectional retrospective study of laboratory records of patients who take electrolytes blood tests containing the data of the serum potassium level. This study is an observational one, and there is no intervention into routine clinical practice either in terms of therapy, or special examinations.

Enrollment: 53,940 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males and females tested in the Russian centres of INVITRO laboratory from 01.01.2015 till 31.12.2016;
• 18 years and older;
• Available electrolytes blood test containing of the serum potassium level of the unique patient fits for interpretation.

Exclusion criteria

• Blood test cannot be interpreted due to various reasons.
• Blood samples with sing of hemolysis